Date & Time
8 December 2023
12:30 | Reception
13.00-14:30 | CME & Lunch

Venue
Li Bao House, 4/F, Century Square,
1-13 D’Aguilar St., Central

MAP (Click here)

Statins are effective in lowering LDL-C levels and are the gold standard for treating hyperlipidemia. However, research has shown that the achievement of targeted LDL-C goals and the optimization of lipid-lowering therapy (LLT) in ASCVD patients remain suboptimal. During this CME lecture, Dr. Wu will offer guidance on individualizing statin and non-statin therapies in this context and address the prevailing inertia to enhance outcomes.

Lecture

Lipid Management for ASCVD patients: What’s new?

Dr. Enoch WU

Presented by
Dr. Enoch WU
Specialist in Endocrinology, Diabetes & Metabolism

Q&A Session

Dr TSANG Man Wo

Moderated by
Dr TSANG Man Wo
Specialist in Endocrinology, Diabetes & Metabolism

Accreditation

[wpdatatable id=”60″]

Notes

  • This lunch symposium is open to all healthcare professionals and is conducted in Cantonese.
  • CME application is in progress, details of which will be posted on this webpage in due course.

Enquiry: +852 3893 6222  (WhatsApp message/call)

Supported by

↓ Register Now ↓